Can oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis

Journal of the American Academy of Dermatology

Volumn 74, Issue 1, 2016, Pages 108-119.e1

  Muranushi, Chiho ^a,b,d   Olsen, Catherine M ^b,d   Green, Adèle C ^b,c,d   Pandeya, Nirmala ^a,b,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d United Kingdom

Author keywords

aspirin; basal cell carcinoma; metaanalysis; NSAIDs; skin cancer; systematic review

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; DATA BASE; DRUG USE; EMBASE; HIGH RISK POPULATION; HUMAN; MEDLINE; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; SKIN CANCER; SYSTEMATIC REVIEW; CARCINOMA, BASAL CELL; FEMALE; GREAT BRITAIN; MALE; ORAL DRUG ADMINISTRATION; PRIMARY PREVENTION; PROCEDURES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARCINOMA, BASAL CELL; FEMALE; GREAT BRITAIN; HUMANS; MALE; PRIMARY PREVENTION; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84953638896     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.08.034     Document Type: Article

References (41)

1. A. Lomas, J. Leonardi-Bee, and F. Bath-Hextall A systematic review of worldwide incidence of nonmelanoma skin cancer Br J Dermatol 166 2012 1069 1080
2. M. Fransen, A. Karahalios, N. Sharma, D.R. English, G.G. Giles, and R.D. Sinclair Non-melanoma skin cancer in Australia Med J Aust 197 2012 565 568
3. J.C. van der Pols, M.M. Heinen, M.C. Hughes, T.I. Ibiebele, G.C. Marks, and A.C. Green Serum antioxidants and skin cancer risk: an 8-year community-based follow-up study Cancer Epidemiol Biomarkers Prev 18 2009 1167 1173
4. R.E. Harris, J. Beebe-Donk, H. Doss, and D. Burr Doss Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review) Oncol Rep 13 2005 559 583
5. T. Luo, H.M. Yan, P. He, Y. Luo, Y.F. Yang, and H. Zheng Aspirin use and breast cancer risk: a meta-analysis Breast Cancer Res Treat 131 2012 581 587
6. C.A. Elmets, J.L. Viner, A.P. Pentland, and et al. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial J Natl Cancer Inst 102 2010 1835 1844
7. A.P. Nunes, K.L. Lapane, and M.A. Weinstock Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial Pharmacoepidemiol Drug Saf 20 2011 922 929
8. B. Zhang, X. Liang, L. Ye, and Y. Wang No chemopreventive effect of nonsteroidal anti-inflammatory drugs on nonmelanoma skin cancer: evidence from meta-analysis PLoS One 9 2014 e96887
9. Y. Zhu, Y. Cheng, R.C. Luo, and A.M. Li Aspirin for the primary prevention of skin cancer: A meta-analysis Oncol Lett 9 2015 1073 1080
10. A. Wysong, M.S. Ally, C.S. Gamba, and et al. Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women's Health Initiative Prev Med 69 2014 8 12
11. D.F. Stroup, J.A. Berlin, S.C. Morton, and et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
12. W.C. Wong, C.S. Cheung, and G.J. Hart Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours Emerg Themes Epidemiol 5 2008 23
13. J.P. Vandenbroucke, E. von Elm, D.G. Altman, and et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration Ann Intern Med 147 2007 W163 W194
14. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
15. W.G. Cochran The combination of estimates from different experiments Biometrics 10 1954 101 129
16. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
17. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
18. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
19. J. Hamling, P. Lee, R. Weitkunat, and M. Ambuhl Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category Stat Med 27 2008 954 970
20. E.K. Cahoon, P. Rajaraman, B.H. Alexander, M.M. Doody, M.S. Linet, and D.M. Freedman Use of nonsteroidal anti-inflammatory drugs and risk of basal cell carcinoma in the United States radiologic technologists study Int J Cancer 130 2012 2939 2948
21. M.C. Clouser, D.J. Roe, J.A. Foote, and R.B. Harris Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial Pharmacoepidemiol Drug Saf 18 2009 276 283
22. M.V. Grau, J.A. Baron, B. Langholz, and et al. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer Int J Cancer 119 2006 682 686
23. J.M. Jeter, J. Han, M.E. Martinez, D.S. Alberts, A.A. Qureshi, and D. Feskanich Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study Cancer Causes Control 23 2012 1451 1461
24. S.A. Johannesdottir, E.T. Chang, F. Mehnert, M. Schmidt, A.B. Olesen, and H.T. Sorensen Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study Cancer 118 2012 4768 4776
25. T. Milan, P.K. Verkasalo, J. Kaprio, and M. Koskenvuo Lifestyle differences in twin pairs discordant for basal cell carcinoma of the skin Br J Dermatol 149 2003 115 123
26. D.C. Torti, B.C. Christensen, C.A. Storm, and et al. Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study J Am Acad Dermatol 65 2011 304 312
27. L.M. Hollestein, M.P. van Herk-Sukel, R. Ruiter, and et al. Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users Int J Cancer 135 2014 157 165
28. D. Reinau, C. Surber, S.S. Jick, and C.R. Meier Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer Int J Cancer 137 2015 144 153
29. H. Husein-El-Ahmed, J. Aneiros-Fernandez, M.T. Gutierrezsalmeron, J. Aneiros-Cachaza, and R. Naranjo-Sintes Effect of non-steroidal anti-inflammatory drugs on the histology of basal cell carcinomas Eur J Dermatol 22 2012 205 210
30. J.Y. Tang, M. Aszterbaum, M. Athar, and et al. Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice Cancer Prev Res 3 2010 25 34
31. U. Vogel, J. Christensen, H. Wallin, S. Friis, B.A. Nexo, and A. Tjonneland Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes Mutat Res 617 2007 138 146
32. M.R. Karagas, T.A. Stukel, V. Umland, and et al. Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study J Invest Dermatol 127 2007 2901 2903
33. H.T. Sørensen, S.P. Johnsen, and B. Nørgård Methodological issues in using prescription and other databases in pharmacoepidemiology Norsk Epidemiologi 11 2001 13 18
34. S.L. West, D.A. Savitz, G. Koch, B.L. Strom, H.A. Guess, and A. Hartzema Recall accuracy for prescription medications: self-report compared with database information Am J Epidemiol 142 1995 1103 1112
35. M. Rossini, S. Maddali Bongi, G. La Montagna, and et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability Arthritis Res Ther 12 2010 R216
36. F. Guadagni, P. Ferroni, R. Palmirotta, G. Del Monte, V. Formica, and M. Roselli Non-steroidal anti-inflammatory drugs in cancer prevention and therapy Anticancer Res 27 2007 3147 3162
37. S. Subongkot, D. Frame, W. Leslie, and D. Drajer Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment Pharmacotherapy 23 2003 9 28
38. M. Amirnia, A. Babaie-Ghazani, A. Fakhrjou, and et al. Immunohistochemical study of cyclooxygenase-2 in skin tumors J Dermatolog Treat 25 2014 380 387
39. C. Muranushi, C.M. Olsen, N. Pandeya, and A.C. Green Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis J Invest Dermatol 135 2015 975 983
40. D.E. Moore Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management Drug Saf 25 2002 345 372
41. R.S. Stern Photocarcinogenicity of drugs Toxicol Lett 102-103 1998 389 392